NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT03409614,Combinations of Cemiplimab (Anti-PD-1 Antibody) and Platinum-based Doublet Chemotherapy in Patients With Lung Cancer,https://clinicaltrials.gov/study/NCT03409614,,COMPLETED,"The primary objectives of this study are:

Part 1: To compare the overall survival (OS) of cemiplimab/chemo-f and cemiplimab/chemo-l/ipi versus platinum-based doublet chemotherapy in the first-line treatment of patients with advanced squamous or nonsquamous non-small cell lung cancer (NSCLC) with tumors expressing PD-L1 in \<50% of tumor cells.

Part 2: To compare the OS of cemiplimab/chemo-f with placebo/chemo-f in the first-line treatment of patients with advanced squamous or non-squamous NSCLC irrespective of PD-L1 expression.

The key secondary objectives are:

Part 1: To compare the progression-free survival (PFS) and objective response rate (ORR) of cemiplimab/chemo-f and cemiplimab/chemo-l/ipi versus chemo-f in the first-line treatment of patients with advanced squamous or non-squamous NSCLC and tumors expressing PD-L1 in \<50% of tumor cells.

Part 2: To compare the PFS and ORR of cemiplimab/chemo-f versus placebo/chemo-f in the first-line treatment of patients with advanced squamous or non-squamous NSCLC irrespective of PD-L1 expression.",NO,Non-small Cell Lung Cancer,DRUG: REGN2810|DRUG: REGN2810/chemo/ipi|OTHER: Chemotherapy|DRUG: Placebo,"Overall survival, Up to 32 months","Progression-free survival, Up to 32 months|Objective response rate, Up to 32 months|Duration of Response (DOR), Up to 32 months|Best overall response (BOR), Up to 32 months|Incidence of Treatment-emergent adverse events (TEAEs), Up to 32 months|Incidence of Dose-limiting toxicities (DLTs), Part 1 only, Up to 32 months|Incidence of serious adverse events (SAEs), Up to 32 months|Incidence of deaths, Up to 32 months|Incidence of laboratory abnormalities, Up to 32 months|Overall survival rate, 12 months|Overall survival rate, 18 months|Overall survival rate, 24 months|Quality of life as measured by EORTC QLQ-C30, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30), Up to 32 months|Quality of life as measured by EORTC QLQ-LC13, Quality of Life Questionnaire Lung Cancer 13 (EORTC QLQ-LC13), Up to 32 months",,Regeneron Pharmaceuticals,Sanofi,ALL,"ADULT, OLDER_ADULT",PHASE3,790,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",R2810-ONC-16113|2017-001311-36,2018-03-06,2025-02-27,2025-02-27,2018-01-24,,2025-03-25,"Regeneron Research Site, Rancho Mirage, California, 92270, United States|Regeneron Research Site, Riverside, California, 92506, United States|Regeneron Research Site, Whittier, California, 90603, United States|Regeneron Research Site, Orange City, Florida, 32763, United States|Regeneron Research Site, Saint Petersburg, Florida, 33709, United States|Regeneron Research Site, Wichita, Kansas, 67214, United States|Regeneron Research Site, Bethesda, Maryland, 20817, United States|Regeneron Research Site, Farmington, New Mexico, 87401, United States|Regeneron Research Site, Gettysburg, Pennsylvania, 17325, United States|Regeneron Research Site, Wien, 1130, Austria|Regeneron Research Site, Baoding, 071105, China|Regeneron research Site, Beijing, 100050, China|Regeneron Research Site, Changsha, 410013, China|Regeneron Research Site, Guangzhou, 510080, China|Regeneron Research Site, Hangzhou Shi, 310002, China|Regeneron Research Site, Hangzhou, 310003, China|Regeneron Research Site, Hangzhou, 310009, China|Regeneron Research Site, Hangzhou, 310013, China|Regeneron Research Site, Jinan, 250013, China|Regeneron Research Site, Linyi City, 276001, China|Regeneron Research Site, Nanjing Shi, 210003, China|Regeneron Research Site, Shanghai, 200040, China|Regeneron Research Site, Shanghai, 200433, China|Regeneron Research Site, Shenyang, 110042, China|Regeneron Research Site, Xiangyang Shi, 441021, China|Regeneron Research Site, Zhengzhou City, 450003, China|Regeneron Research Site, Zhengzhou, 450008, China|Regeneron Research Site, Bayonne, 64100, France|Regeneron Research Site, Creteil, 94010, France|Regeneron Research Site, Le Mans, 72000, France|Regeneron Research Site, Lille, 59037, France|Regeneron Research Site, Lyon, 69310, France|Regeneron Research Site, Mont-de-Marsan, 40024, France|Regeneron Research Site, Saint Herblain Cedex, 44805, France|Regeneron Research Site, Saint-Mandé, 94160, France|Regeneron Research Site, Strasbourg, 67091, France|Regeneron Research Site, Batumi, 6000, Georgia|Regeneron Research Site, Tbilisi, 0112, Georgia|Regeneron Research Site, Tbilisi, 0144, Georgia|Regeneron Research Site #1, Tbilisi, 0159, Georgia|Regeneron Research Site #2, Tbilisi, 0159, Georgia|Regeneron Research Site, Tbilisi, 0186, Georgia|Regeneron Research Site, Thessaloniki, Macedonia, 54645, Greece|Regeneron Research Site, Athens, 11527, Greece|Regeneron Research Site, Kifisia, 14564, Greece|Regeneron Research Site, Larissa, 41334, Greece|Regeneron Research Site, Pylaia, 57001, Greece|Regeneron Research Site, Thessaloniki, 54007, Greece|Regeneron Research Site, Dublin, 9, Ireland|Regeneron Research Site, Limerick, V94F858, Ireland|Regeneron Research Site, Cremona, 26100, Italy|Regeneron Research Site, Meldola, 47014, Italy|Regeneron Research Site, Milano, 20162, Italy|Regeneron Research Site, Monserrato, 09042, Italy|Regeneron Research Site, Piacenza, 29121, Italy|Regeneron Research Site, Saronno, 21047, Italy|Regeneron Research Site, Terni, 05100, Italy|Regeneron Research Site, Treviglio, 24047, Italy|Regeneron Research Site, Cheongju-si, 28644, Korea, Republic of|Regeneron Research Site, Incheon, 21565, Korea, Republic of|Regeneron Research Site, Jeonju, 54907, Korea, Republic of|Regeneron Research Site, Seongnam-si, 13496, Korea, Republic of|Regeneron Research Site, Seongnam-si, 13620, Korea, Republic of|Regeneron Research Site, Seoul, 05368, Korea, Republic of|Regeneron Research Site, Seoul, 05505, Korea, Republic of|Regeneron Research Site, Seoul, 06351, Korea, Republic of|Regeneron Research Site, Suwon-si, 16499, Korea, Republic of|Regeneron Research Site, Klaipeda, LT-92288, Lithuania|Regeneron Research Site, Vilnius, LT-08660, Lithuania|Regeneron Research Site, Kuala Lumpur, Wilayah Persekutuan, 59100, Malaysia|Regeneron Research Site, Johor Bahru, 81100, Malaysia|Regeneron Research Site, Kota Kinabalu, 88996, Malaysia|Regeneron Research Site, Kuala Lumpur, 56000, Malaysia|Regeneron Research Site, Kuala Lumpur, 59100, Malaysia|Regeneron Research Site, Kuantan, 25100, Malaysia|Regeneron Research Site, Penang, 10350, Malaysia|Regeneron Research Site, Pulau Pinang, 10990, Malaysia|Regeneron Research Site, Tanjung Bungah, 11200, Malaysia|Regeneron Research Site, Gdynia, Pomorskie, 81-519, Poland|Regeneron Research Site, Lublin, 20-093, Poland|Regeneron Research Site, Olsztyn, 10-357, Poland|Regeneron Research Site, Otwock, 05-400, Poland|Regeneron Research Site, Poznan, 60-693, Poland|Regeneron Research Site, Rzeszow, 35-021, Poland|Regeneron Research Site, Torun, 87-100, Poland|Regeneron Research Site, Wodzisław Śląski, 44-300, Poland|Regeneron Research Site, Łódź, 90-302, Poland|Regeneron Research Site, Cluj Napoca, 400006, Romania|Regeneron Research Site, Cluj Napoca, 400124, Romania|Regeneron Research Site, Craiova, 200094, Romania|Regeneron Research Site, Craiova, 200347, Romania|Regeneron Research Site, Craiova, 200385, Romania|Regeneron Research Site, Ufa, Republic Bashkortost, 450054, Russian Federation|Regeneron Research Site, Arkhangel'sk, 163045, Russian Federation|Regeneron Research Site, Belgorod, 308010, Russian Federation|Regeneron Research Site, Chelyabinsk, 454048, Russian Federation|Regeneron Research Site, Ekaterinburg, 620036, Russian Federation|Regeneron Research Site, Kaluga, 248007, Russian Federation|Regeneron Research Site, Kazan, 420029, Russian Federation|Regeneron Research Site, Kursk, 305016, Russian Federation|Regeneron Research Site, Moscow region, 143444, Russian Federation|Regeneron Research Site, Moscow, 115478, Russian Federation|Regeneron Research Site, Moscow, 121467, Russian Federation|Regeneron Research Site, Omsk, 644013, Russian Federation|Regeneron Research Site, Pushkin, 196603, Russian Federation|Regeneron Research Site, Pyatigorsk, 357502, Russian Federation|Regeneron Research Site, Saint Petersburg, 191104, Russian Federation|Regeneron Research Site, Saint Petersburg, 197758, Russian Federation|Regeneron Research Site, Saint Petersburg, 198255, Russian Federation|Regeneron Research Site, Samara, 443001, Russian Federation|Regeneron Research Site, Saransk, 430032, Russian Federation|Regeneron Research Site, Sochi, 354057, Russian Federation|Regeneron Research Site, Tomsk, 634028, Russian Federation|Regeneron Research Site, Tomsk, 634050, Russian Federation|Regeneron Research Site, Banka, 92101, Slovakia|Regeneron Research Site #2, Ratchathewi, Bangkok, 10400, Thailand|Regeneron Research Site, Muang, Chiang Rai, 57000, Thailand|Regeneron Research Site, A. Mueang, Lampang, 52000, Thailand|Regeneron Research Site, Muang, Phitsanulok, 65000, Thailand|Regeneron Research Site, Hat Yai, Songkhla, 90110, Thailand|Regeneron Research Site, Muang, 15000, Thailand|Regeneron Research Site #1, Ratchathewi, 10400, Thailand|Regeneron Research Site, Udonthani, 41330, Thailand|Regeneron Research Site, Adana, 01120, Turkey|Regeneron Research Site, Ankara, 06100, Turkey|Regeneron Research Site, Istanbul, 34000, Turkey|Regeneron Research Site, Istanbul, 34093, Turkey|Regeneron Research Site, Dnipro, 49102, Ukraine|Regeneron Research Site, Kharkiv, 61070, Ukraine|Regeneron Research Site, Kiev, 03022, Ukraine|Regeneron Research Site, Kirovohrad, 25006, Ukraine|Regeneron Research Site, Uzhgorod, 88014, Ukraine|Regeneron Research Site, Vinnytsia, 21029, Ukraine",
